Financial Instruments Measured at Fair Value and Concentrations of Credit Risk - Additional Information (Detail) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Fair Value Concentration Of Risk Financial Statement Captions [Line Items] | ||
| Fair value of financing leases | $ 14.5 | |
| Short-term investments | $ 0.0 | |
| Unrealized commodity derivative losses from hedging contracts sold | 0.0 | |
| Corporate Debt Securities [Member] | ||
| Fair Value Concentration Of Risk Financial Statement Captions [Line Items] | ||
| Other financial instruments | $ 0.0 |
| X | ||||||||||
- Definition Finance lease obligations fair value disclosure. No definition available.
|
| X | ||||||||||
- Definition Other financial instruments. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|